Clinical Trial Update: Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of CBX-12 in adults with advanced or metastatic refractory solid tumors. The trial includes multiple cancer types and is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Epithelial Ovarian Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Small Cell Lung Cancer
• Urothelial Carcinoma

Drugs mentioned

• CBX-12

Snippet

Sponsor: Cybrexa Therapeutics | Conditions: Solid Tumor, Adult, Epithelial Ovarian Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING